USANA Health Sciences Inc (USNA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, USANA Health Sciences Inc (USNA) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.76 Million) by net assets ($594.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See USANA Health Sciences Inc net asset quality index to measure how much of total assets are equity-financed.
USANA Health Sciences Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is USANA Health Sciences Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
USANA Health Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of USANA Health Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aluflexpack AG
SW:AFP
|
0.116x |
|
Famous Brands Ltd
JSE:FBR
|
0.311x |
|
BAIC Motor Corp Ltd
F:2B5
|
0.087x |
|
Shin Hai Gas Corp
TW:9926
|
0.073x |
|
Jasmine International Public Company Limited
BK:JAS
|
0.020x |
|
Viking Tech
TWO:3624
|
-0.009x |
|
Shenzhen Sine Electric Co. Ltd. A
SHG:688395
|
0.031x |
|
Advanced Ceramic X
TWO:3152
|
0.017x |
Annual Cash Flow Conversion Efficiency for USANA Health Sciences Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of USANA Health Sciences Inc from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see USNA market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $586.27 Million | $22.35 Million | 0.038x | -63.35% |
| 2024-12-31 | $586.33 Million | $60.99 Million | 0.104x | -26.78% |
| 2023-12-31 | $497.20 Million | $70.64 Million | 0.142x | -40.59% |
| 2022-12-31 | $434.47 Million | $103.90 Million | 0.239x | -22.05% |
| 2021-12-31 | $395.12 Million | $121.23 Million | 0.307x | -15.52% |
| 2020-12-31 | $441.65 Million | $160.40 Million | 0.363x | +0.79% |
| 2019-12-31 | $351.71 Million | $126.73 Million | 0.360x | -7.35% |
| 2018-12-31 | $391.15 Million | $152.12 Million | 0.389x | +14.11% |
| 2017-12-31 | $363.21 Million | $123.78 Million | 0.341x | -19.10% |
| 2016-12-31 | $325.29 Million | $137.03 Million | 0.421x | +6.14% |
| 2015-12-31 | $280.85 Million | $111.47 Million | 0.397x | -13.15% |
| 2014-12-31 | $230.16 Million | $105.19 Million | 0.457x | +20.39% |
| 2013-12-31 | $260.52 Million | $98.89 Million | 0.380x | -24.10% |
| 2012-12-31 | $185.57 Million | $92.81 Million | 0.500x | +24.06% |
| 2011-12-31 | $173.91 Million | $70.11 Million | 0.403x | -11.48% |
| 2010-12-31 | $145.17 Million | $66.11 Million | 0.455x | +4.31% |
| 2009-12-31 | $74.37 Million | $32.47 Million | 0.437x | -69.76% |
| 2008-12-31 | $31.84 Million | $45.96 Million | 1.444x | -2.52% |
| 2007-12-31 | $38.64 Million | $57.22 Million | 1.481x | +47.30% |
| 2006-12-31 | $60.20 Million | $60.52 Million | 1.005x | -4.24% |
| 2005-12-31 | $45.74 Million | $48.02 Million | 1.050x | +31.55% |
| 2004-12-31 | $47.84 Million | $38.18 Million | 0.798x | -0.19% |
| 2003-12-31 | $44.37 Million | $35.48 Million | 0.800x | -9.26% |
| 2002-12-31 | $18.09 Million | $15.94 Million | 0.881x | +28.64% |
| 2001-12-31 | $14.53 Million | $9.95 Million | 0.685x | +116.77% |
| 2000-12-31 | $12.87 Million | $4.07 Million | 0.316x | -72.82% |
| 1999-12-31 | $12.90 Million | $15.00 Million | 1.163x | +235.67% |
| 1998-12-31 | $30.60 Million | $10.60 Million | 0.346x | -5.84% |
| 1997-12-31 | $19.30 Million | $7.10 Million | 0.368x | +8.61% |
| 1996-12-31 | $12.40 Million | $4.20 Million | 0.339x | -42.68% |
| 1995-12-31 | $6.60 Million | $3.90 Million | 0.591x | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more